Key result
Early screening and multidisciplinary Renal Barocrinology strategies address obesity-driven chronic kidney disease risks.
Why the study?
Obesity is a major risk factor for chronic kidney disease, with increasing incidence of obesity-related nephropathy requiring multidisciplinary prevention and management.
Highlights the critical need for routine kidney function screening and a multidisciplinary approach to mitigate the growing burden of obesity-related nephropathy.
Supports CKD screening in obesity; leaves open whether Renal Barocrinology improves outcomes.
Obesity is been acknowledged to be a major risk factor for chronic kidney disease (CKD), contributing to both its onset and progression. Over past few decades, the obesity epidemic has lead to an increased incidence of obesityrelated nephropathy, characterised by glomerular hyperfiltration, hypertrophy, and progressive glomerulosclerosis. This review highlights the need for multidisciplinary action to prevent and manage obesityrelated nephropathy. We reiterate the current necessity of routine kidney function screening in people with obesity. We also propose an integrated concept of Renal Barocrinology. This will focus on early screening and preventive strategies, mitigating long-term burden of CKD and its complications, and improving patient outcomes through a collaborative approach.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2025) conducted a review in Chronic Kidney Disease and Obesity. Obesity vs. Normal weight was evaluated. Obesity is a major risk factor for chronic kidney disease, driving the need for early screening and a multidisciplinary approach termed Renal Barocrinology to mitigate long-term kidney damage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: